ZW4285A1 - Dopamine-beta-hydroxylase inhibitors - Google Patents
Dopamine-beta-hydroxylase inhibitorsInfo
- Publication number
- ZW4285A1 ZW4285A1 ZW42/85A ZW4285A ZW4285A1 ZW 4285 A1 ZW4285 A1 ZW 4285A1 ZW 42/85 A ZW42/85 A ZW 42/85A ZW 4285 A ZW4285 A ZW 4285A ZW 4285 A1 ZW4285 A1 ZW 4285A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- dopamine
- beta
- hydroxylase inhibitors
- hydroxylase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
- C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59066584A | 1984-03-19 | 1984-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZW4285A1 true ZW4285A1 (en) | 1985-06-26 |
Family
ID=24363168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZW42/85A ZW4285A1 (en) | 1984-03-19 | 1985-03-12 | Dopamine-beta-hydroxylase inhibitors |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR850006189A (da) |
DK (2) | DK118985A (da) |
FI (1) | FI83309C (da) |
HU (1) | HU194184B (da) |
IL (1) | IL74586A (da) |
NO (1) | NO162616C (da) |
NZ (2) | NZ211440A (da) |
PH (1) | PH21032A (da) |
ZW (1) | ZW4285A1 (da) |
-
1985
- 1985-03-12 ZW ZW42/85A patent/ZW4285A1/xx unknown
- 1985-03-13 IL IL74586A patent/IL74586A/xx unknown
- 1985-03-13 PH PH31983A patent/PH21032A/en unknown
- 1985-03-14 NZ NZ211440A patent/NZ211440A/xx unknown
- 1985-03-14 NZ NZ222876A patent/NZ222876A/xx unknown
- 1985-03-15 DK DK118985A patent/DK118985A/da not_active Application Discontinuation
- 1985-03-18 KR KR1019850001737A patent/KR850006189A/ko not_active Application Discontinuation
- 1985-03-18 HU HU85996A patent/HU194184B/hu not_active IP Right Cessation
- 1985-03-18 NO NO851056A patent/NO162616C/no unknown
- 1985-03-18 FI FI851073A patent/FI83309C/fi not_active IP Right Cessation
-
1991
- 1991-11-20 DK DK189691A patent/DK189691A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI851073L (fi) | 1985-09-20 |
NO162616C (no) | 1990-01-24 |
FI83309C (fi) | 1991-06-25 |
HU194184B (en) | 1988-01-28 |
DK118985D0 (da) | 1985-03-15 |
NZ211440A (en) | 1988-09-29 |
DK118985A (da) | 1985-09-20 |
HUT37602A (en) | 1986-01-23 |
NZ222876A (en) | 1988-09-29 |
NO851056L (no) | 1985-09-20 |
NO162616B (no) | 1989-10-16 |
DK189691D0 (da) | 1991-11-20 |
IL74586A0 (en) | 1985-06-30 |
KR850006189A (ko) | 1985-10-02 |
DK189691A (da) | 1991-11-20 |
FI83309B (fi) | 1991-03-15 |
FI851073A0 (fi) | 1985-03-18 |
PH21032A (en) | 1987-06-30 |
IL74586A (en) | 1988-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT78388A (en) | Dopamine-beta-hydroxylase inhibitors | |
PL256327A1 (en) | Holding handage | |
ZA884838B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA883851B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT83076A (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA874396B (en) | Irreversible dopamine-beta-hydroxylase inhibitors | |
PT83628B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA889709B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA889667B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT84904A (en) | Dopamine-beta-hydroxylase inhibitors | |
PT85596B (en) | Dopamine-beta-hydroxylase inhibitors | |
PT86513A (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA882100B (en) | Dopamine-beta-hydroxylase inhibitors | |
GB8500713D0 (en) | Swab | |
ZA868234B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA86949B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA842963B (en) | Dopamine-beta-hydroxylase inhibitors | |
ZW4285A1 (en) | Dopamine-beta-hydroxylase inhibitors | |
ZA842962B (en) | Dopamine-beta-hydroxylase inhibitors | |
DE3477926D1 (en) | Dopamine-beta-hydroxylase inhibitors | |
EP0175291A3 (en) | Novel alpha-d-mannosidase inhibitor | |
GB8412295D0 (en) | Pipes | |
ZA882275B (en) | Dopamine-beta-hydroxylase inhibitors | |
GB8424623D0 (en) | Swabs | |
IE842780L (en) | 5-lipoxygenase inhibitors |